Evidence map›Paper›PMID 28966992›Full record

ArticleHepatology communications2017

Hepatic Inositol 1,4,5 Trisphosphate Receptor Type 1 Mediates Fatty Liver.

Colleen N Feriod, Andre Gustavo Oliveira, Mateus T Guerra, Lily Nguyen, Kisha Mitchell Richards, Michael J Jurczak, Hai-Bin Ruan, Joao Paulo Camporez, Xiaoyong Yang, Gerald I Shulman and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Hepatology communications, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 76 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Enhanced CaNature communications · 2023
    Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Role of CaInternational journal of molecular medicine · 2022
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Colleen N FeriodDepartment of Cellular and Molecular Physiology, Yale University School of Medicine New Haven, CT 06520.
Andre Gustavo OliveiraSection of Digestive Diseases, Internal Medicine, Yale University School of Medicine New Haven, CT 06520.
Mateus T GuerraSection of Digestive Diseases, Internal Medicine, Yale University School of Medicine New Haven, CT 06520.
Lily NguyenDepartment of Pharmacology, Yale University School of Medicine New Haven, CT 06520.
Kisha Mitchell RichardsDepartment of Pathology, Yale University School of Medicine New Haven, CT 06520.
Michael J JurczakDepartment of Internal Medicine, Yale University School of Medicine New Haven, CT 06520.
Hai-Bin RuanDepartment of Comparative Medicine, Yale University School of Medicine New Haven, CT 06520.
Joao Paulo CamporezDepartment of Internal Medicine, Yale University School of Medicine New Haven, CT 06520.
Xiaoyong YangDepartment of Cellular and Molecular Physiology, Yale University School of Medicine New Haven, CT 06520.
Gerald I ShulmanDepartment of Cellular and Molecular Physiology, Yale University School of Medicine New Haven, CT 06520.
Anton M BennettDepartment of Pharmacology, Yale University School of Medicine New Haven, CT 06520.
Michael H NathansonSection of Digestive Diseases, Internal Medicine, Yale University School of Medicine New Haven, CT 06520.
Barbara E EhrlichDepartment of Cellular and Molecular Physiology, Yale University School of Medicine New Haven, CT 06520.
Yale University · USHoward Hughes Medical Institute · US

Funding

Yale Diabetes Research CenterP30DK045735 · NIDDK · YALE UNIVERSITY · PI Kevan C Herold, GERALD I SHULMAN · 1993 to 2026
$44.0M
Yale Liver CenterP30DK034989 · NIDDK · YALE UNIVERSITY · PI YASUKO IWAKIRI · 1986 to 2026
$31.1M
Translational CoreP01DK057751 · NIDDK · YALE UNIVERSITY · PI YANG, XIAOYONG · 2001 to 2020
$25.6M
Yale Mouse Metabolic Phenotyping CenterU24DK059635 · NIDDK · YALE UNIVERSITY · PI SHULMAN, GERALD I · 2001 to 2015
$8.9M
CALCIUM WAVES IN HEPATOCYTES--MECHANISMS AND EFFECTSR01DK045710 · NIDDK · YALE UNIVERSITY · PI NATHANSON, MICHAEL H · 1999 to 2014
$5.7M
Center for Polycystic Kidney Disease Research at YaleP30DK090744 · NIDDK · YALE UNIVERSITY · PI CAPLAN, MICHAEL J. · 2010 to 2014
$5.6M
Mechanisms of Lipid-Induced Hepatic Insulin ResistanceR01DK040936 · NIDDK · YALE UNIVERSITY · PI SHULMAN, GERALD I · 1989 to 2015
$5.1M
Regulation of cholangiocytes by InsP3 receptor isoformsR01DK061747 · NIDDK · YALE UNIVERSITY · PI EHRLICH, BARBARA E., NATHANSON, MICHAEL H · 2003 to 2012
$3.4M
NIDDK NIH HHS P01 DK057751NIDDK NIH HHS P30 DK034989NIDDK NIH HHS P30 DK045735NIDDK NIH HHS P30 DK090744NIDDK NIH HHS R01 DK040936NIDDK NIH HHS R01 DK045710NIDDK NIH HHS R01 DK061747NIDDK NIH HHS U24 DK059635
6 · The paper itself

Abstract

Fatty liver is the most common type of liver disease, affecting nearly one third of the US population and more than half a billion people worldwide. Abnormalities in ER calcium handling and mitochondrial function each have been implicated in abnormal lipid droplet formation. Here we show that the type 1 isoform of the inositol 1,4,5-trisphosphate receptor (InsP

conclusionInsP

Indexed as

Calciumdiabetesendoplasmic reticulumhepatitissteatosis

Identifiers

PMID28966992
PMCPMC5613674
OpenAlexW2554806482

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.